Literature DB >> 4006632

Ulcerative colitis and colonic cancer. Problems in assessing the diagnostic usefulness of mucosal dysplasia.

D F Ransohoff, R H Riddell, B Levin.   

Abstract

To assess the association of mucosal dysplasia and colonic cancer in patients with ulcerative colitis and to avoid bias in biopsy interpretation that may have affected results of previous studies, the authors examined coded histology slides from colectomy specimens of 22 patients who had ulcerative colitis and colonic cancer and 22 patients who had ulcerative colitis but no colonic cancer. As expected, it was found that dysplasia occurred contiguous to each cancer. However, at a distance from the cancer (i.e., in histology blocks not containing cancer), some dysplasia was found (low or high grade) in 16/22 cases (73 percent), and high grade dysplasia in 11/22 cases (50 percent). These results suggest that there may be somewhat weaker association than previously reported between colonic cancer and dysplasia at a distance from the colonic cancer. Further, these results suggest that, in studies of dysplasia, it is important to avoid bias in biopsy interpretation and to describe sampling methods.

Entities:  

Mesh:

Year:  1985        PMID: 4006632     DOI: 10.1007/bf02560215

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  19 in total

Review 1.  Colonoscopic surveillance in ulcerative colitis--dysplasia through the looking glass.

Authors:  J B Fozard; M F Dixon
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

2.  Colonoscopy, mucosal biopsy and brush cytology in the assessment of patients with colorectal inflammatory bowel disease.

Authors:  W H Isbister; R K Gupta
Journal:  Surg Endosc       Date:  1989       Impact factor: 4.584

3.  DNA aneuploidy in Crohn's disease and ulcerative colitis: results of a comparative flow cytometric study.

Authors:  R Porschen; U Robin; A Schumacher; S Schauseil; F Borchard; K J Hengels; G Strohmeyer
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

Review 4.  Screening for gastrointestinal cancer: an epidemiological review.

Authors:  J Weil; M J Langman
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

Review 5.  How do we assess the value of surveillance techniques in ulcerative colitis?

Authors:  C N Bernstein
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

6.  Cancer in Inflammatory Bowel Disease.

Authors:  Thomas A. Ullman
Journal:  Curr Treat Options Gastroenterol       Date:  2002-06

7.  Colonic cancer in a patient with primary sclerosing cholangitis and long-standing ulcerative colitis.

Authors:  M Seo; M Okada; S Osamura; S Hara; T Umeno; K Maeshiro; Y Yamada; K Yuh
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

8.  A decision analysis of surveillance for colorectal cancer in ulcerative colitis.

Authors:  F Delcò; A Sonnenberg
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

9.  Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer.

Authors:  B Levin; J Lennard-Jones; R H Riddell; D Sachar; S J Winawer
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

10.  Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.

Authors:  M D Rutter; B P Saunders; G Schofield; A Forbes; A B Price; I C Talbot
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.